<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.otf"); }
#f1 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff14; src: url("14.otf"); }
#f2 { font-family:ff14,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.otf"); }
#f3 { font-family:ff4,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff6; src: url("6.otf"); }
#f4 { font-family:ff6,sans-serif; font-weight:normal; font-style:italic; }
@font-face { font-family: ff7; src: url("7.otf"); }
#f5 { font-family:ff7,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff11; src: url("11.otf"); }
#f6 { font-family:ff11,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff12; src: url("12.otf"); }
#f7 { font-family:ff12,monospace; font-weight:bold; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="585" height="783" src="page5.png">
<div class="txt" style="position:absolute; left:42px; top:41px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Cryo-EM Structure of </span><span id="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">A. baumannii </span><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Efﬂux Pump</span></div>
<div class="txt" style="position:absolute; left:540px; top:38px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">®</span></div>
<div class="txt" style="position:absolute; left:41px; top:351px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">FIG 2 </span><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Overall cryo-EM structure of the </span><span id="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">A. baumannii </span><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">AdeB multidrug efﬂux pump. (A) Ribbon diagram of the structure of the AdeB trimer viewed in the</span></div>
<div class="txt" style="position:absolute; left:41px; top:360px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">membrane plane. Each subunit of AdeB is labeled with a different color. Subdomains DN, DC, PN2, PC1, and PC2 are labeled on the front protomer. PN1 is</span></div>
<div class="txt" style="position:absolute; left:41px; top:369px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">located behind PN2, PC1, and PC2 and is therefore not labeled in this view. No channel is formed in the periplasmic domain of each protomer. The bound PE</span></div>
<div class="txt" style="position:absolute; left:41px; top:378px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">lipids are depicted as spheres (gray, carbon; blue, nitrogen; orange, phosphorus; red, oxygen). (B) The PE binding site at the interior wall of the central cavity</span></div>
<div class="txt" style="position:absolute; left:41px; top:386px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">of an AdeB protomer. The EM density of the bound PE is in blue mesh and shown at 5 </span><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,0);">␴</span><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">. The secondary structural elements of the AdeB protomer involved</span></div>
<div class="txt" style="position:absolute; left:41px; top:396px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">in binding this lipid molecule are colored pink. (C) The PE binding site at the interface between two AdeB protomers. The EM density of the bound PE is in</span></div>
<div class="txt" style="position:absolute; left:41px; top:404px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">blue mesh and shown at 5 </span><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,0);">␴</span><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">. The secondary structural elements of the two AdeB protomers that form the protein-protein interface are colored pink and gray.</span></div>
<div class="txt" style="position:absolute; left:41px; top:444px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">to distinguish between residues in the two subunits) are positioned to form favorable</span></div>
<div class="txt" style="position:absolute; left:41px; top:456px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">hydrophobic interactions with the hydrocarbon chains of bound PE (Fig. 2C). Similar to</span></div>
<div class="txt" style="position:absolute; left:41px; top:468px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">the other lipid site described above, this PE lipid interacts with a cationic lysine residue,</span></div>
<div class="txt" style="position:absolute; left:41px; top:480px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">K29</span><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">=</span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">, to form a weak hydrogen bond, further stabilizing the binding (Fig. 2C). We</span></div>
<div class="txt" style="position:absolute; left:41px; top:492px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">suspected that this bound PE lipid, which is located at the protein-protein interface,</span></div>
<div class="txt" style="position:absolute; left:41px; top:504px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">may be important for stabilizing the trimeric oligomerization of this multidrug efﬂux</span></div>
<div class="txt" style="position:absolute; left:41px; top:516px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">pump. It is interesting to note that the locations of these two AdeB lipid-binding sites</span></div>
<div class="txt" style="position:absolute; left:41px; top:528px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">coincide with the corresponding positions of two of the 24 bound lipid molecules</span></div>
<div class="txt" style="position:absolute; left:41px; top:540px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">reported in the cryo-EM AcrB structure (29).</span></div>
<div class="txt" style="position:absolute; left:53px; top:552px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Periplasmic multidrug binding sites. </span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Like other structures of HAE-RND efﬂux</span></div>
<div class="txt" style="position:absolute; left:41px; top:564px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">pumps, a cleft is formed between subdomains PC1 and PC2 in the periplasm of AdeB</span></div>
<div class="txt" style="position:absolute; left:41px; top:576px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">(Fig. 3). Presumably, a drug molecule entering into the periplasmic cleft will bind at the</span></div>
<div class="txt" style="position:absolute; left:41px; top:588px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">proximal multidrug binding site. This drug will then pass through the gate loop</span></div>
<div class="txt" style="position:absolute; left:41px; top:600px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">(G-loop) and be delivered to the distal multidrug binding site for extrusion. In AcrB, the</span></div>
<div class="txt" style="position:absolute; left:41px; top:612px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">entrance of this periplasmic cleft is surrounded by residues F664, F666, L668, R717, and</span></div>
<div class="txt" style="position:absolute; left:41px; top:624px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">L828, and these residues have been shown to be important for drug recognition (34, 36,</span></div>
<div class="txt" style="position:absolute; left:41px; top:636px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">37). However, these residues are not conserved among the HAE-RND pumps, suggest-</span></div>
<div class="txt" style="position:absolute; left:41px; top:648px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">ing that they may play a role in substrate speciﬁcity and selectivity. The corresponding</span></div>
<div class="txt" style="position:absolute; left:41px; top:660px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">ﬁve residues in AdeB are M656, V658, P660, W708, and A819 (Fig. 3A). These residues</span></div>
<div class="txt" style="position:absolute; left:41px; top:672px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">are mostly hydrophobic in nature, suggesting that AdeB may tend to choose hydro-</span></div>
<div class="txt" style="position:absolute; left:41px; top:684px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">phobic compounds as the natural substrates. Interestingly, the entrance of the periplas-</span></div>
<div class="txt" style="position:absolute; left:41px; top:696px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">mic cleft of CusA (30–32), a speciﬁc heavy-metal efﬂux (HME)-RND pump that recog-</span></div>
<div class="txt" style="position:absolute; left:41px; top:708px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">nizes and extrudes Cu(I) and Ag(I) ions, is surrounded with residues N660, W662, P664,</span></div>
<div class="txt" style="position:absolute; left:41px; top:720px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">L714, and D827. These residues are more polar and negatively charged in nature than</span></div>
<div class="txt" style="position:absolute; left:41px; top:732px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">are those of AdeB and AcrB, suggesting that CusA may tend to select positively charged</span></div>
<div class="txt" style="position:absolute; left:41px; top:752px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">July/August 2019 Volume 10 Issue 4 e01295-19</span></div>
<div class="txt" style="position:absolute; left:492px; top:752px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">mbio.asm.org </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">5</span></div>
</body>
</html>
